Targin oxycodone/naloxone regulatory update

Germany's Federal Joint Committee (G-BA) said it plans to assess pain drug Targin oxycodone/naloxone from Mundipharma, which was launched before drug pricing law AMNOG took effect. G-BA already plans to evaluate Nucynta tapentadol from Gruenenthal Group (Aachen, German), a second pain drug launched prior to AMNOG. Dossiers for both are due Feb. 15, 2014. The dossier for Nucynta was previously due Oct. 15. ...